Mukhyamantri Haemophilia Yojana, implemented by the Health Department, Government of Bihar through the State Health Society Bihar, aims to provide free Emicizumab treatment to eligible haemophilia patients across the state. The scheme was approved by the Bihar Cabinet on 30 September 2026, with detailed operational guidelines expected to be released by the government.
Bihar Mukhyamantri Haemophilia Yojana Highlights | |
|---|---|
| Scheme Name | Mukhyamantri Haemophilia Yojana |
| Approval Date | 30 September 2026 |
| Nodal Department | Health Department, Government of Bihar |
| Implementing Agency | State Health Society Bihar |
| Funding Source | Mukhyamantri Chikitsa Sahayata Kosh |
| Objective | Provide free Emicizumab treatment to haemophilia patients |
| Key Benefit | Government funded Emicizumab therapy |
| First Year Allocation | Rs. 26.33 crore |
| Expected Beneficiaries | Around 255 registered haemophilia patients |
| Eligibility | Bihar residents diagnosed with Haemophilia A or Haemophilia B |
| Treatment Centres | Government medical colleges and designated haemophilia care centres |
| Application Status | Detailed guidelines awaited |
| Official Portal | thalassemiaregistry.bihar.gov.in |
Introduction of Bihar Mukhyamantri Haemophilia Yojana: A Brief Insight
For many haemophilia patients in Bihar, accessing advanced treatment has remained a major challenge because of the extremely high cost of modern medicines. Recognising this need, the Bihar Cabinet approved Mukhyamantri Haemophilia Yojana on 30 September 2026 to provide dedicated treatment support to affected patients.
The scheme is being implemented by the Health Department, Government of Bihar through the State Health Society, Bihar under the Mukhyamantri Chikitsa Sahayata Kosh. Its primary objective is to ensure that eligible haemophilia patients receive access to advanced treatment without having to bear the enormous financial burden themselves.
Under Mukhyamantri Haemophilia Yojana, eligible beneficiaries will receive government funded Emicizumab, an advanced medicine used in the management of Haemophilia A and Haemophilia B. To support this initiative, the Bihar Government has sanctioned Rs. 26.33 crore for the first year. Since the cost of a single vial is close to Rs. 39,000 and patients often require multiple doses throughout the year, the scheme offers significant financial relief to affected families.
The initial phase is expected to benefit around 255 registered haemophilia patients across Bihar. Treatment and medicine distribution will be carried out through government medical college hospitals and specialised haemophilia treatment centres operating under the state’s healthcare network.
As the scheme has been approved recently, detailed operational guidelines and the complete beneficiary enrollment process are still being finalised by the concerned authorities. Patients and their families should stay in touch with their nearest government medical college hospital and the State Health Society Bihar for official updates.
Patients can also explore the Ayushman Bharat PM Jan Arogya Yojana, and senior citizens above 70 can check the Ayushman Bharat Vay Vandana Card Scheme, both offering complementary health coverage.
Haemophilia patients, caregivers, and individuals looking for more healthcare and welfare schemes available under the Bihar Government can explore all available programmes on our Bihar Government Welfare Schemes List page.
Benefits Provided to Eligible Beneficiaries
Mukhyamantri Haemophilia Yojana makes advanced haemophilia treatment accessible to patients who would otherwise struggle to afford it. By providing access to modern non factor therapy through Government support, the scheme helps improve treatment outcomes and reduces the financial burden on affected families.
Access to Emicizumab Free of Cost
- Government funded supply of Emicizumab, an advanced non factor bispecific antibody medicine used for haemophilia treatment
- Helps significantly reduce the frequency of spontaneous internal bleeding episodes, improving the quality of life for patients
- Administered through subcutaneous injections, offering a more convenient treatment option compared to frequent intravenous factor infusions
Major Financial Relief for Families
- Each vial of Emicizumab costs approximately Rs. 39,000 to Rs. 39,723
- A patient weighing around 30 kg may require nearly 70 to 78 injections in a year, depending on the prescribed treatment plan
- The scheme shields families from a treatment expense that can otherwise run into several lakhs of rupees annually
Supported Through a Dedicated Budget
- Rs. 26.33 crore has been sanctioned during the initial phase for the procurement of Emicizumab
- Approximately 255 registered haemophilia patients across Bihar are expected to benefit from the scheme in its first phase of implementation
Treatment Through Specialised Government Healthcare Facilities
Treatment under Mukhyamantri Haemophilia Yojana is provided through Bihar’s established Integrated Centre for Hemoglobinopathies and Haemophilia (ICHH) network, including dedicated Day Care Centres functioning at major Government Medical College Hospitals across the state.
Eligibility Conditions Required to be Fulfilled
The Health Department of the Government of Bihar has designed Mukhyamantri Haemophilia Yojana to support patients who require advanced haemophilia treatment and face significant financial challenges in accessing it. The scheme operates under the broader framework of the Mukhyamantri Chikitsa Sahayata Kosh.
- Must be a permanent resident of Bihar
- Must be diagnosed with Haemophilia A or Haemophilia B, confirmed through laboratory testing at a Government health facility
- Must genuinely require Emicizumab or other prescribed non factor therapy, based on the recommendation of a treating specialist
- Must be registered on the State Health Society Bihar Thalassemia and Hemophilia Portal
Who This Scheme Helps the Most
Mukhyamantri Haemophilia Yojana is especially beneficial for patients from economically weaker families, as the cost of advanced non factor haemophilia treatment can be extremely high. The scheme helps ensure that financial limitations do not become a barrier to receiving life saving and long term treatment.
Who Won’t Qualify
- Applicants who are not residents of Bihar
- Individuals without a confirmed diagnosis of Haemophilia A or Haemophilia B
- Patients who have not completed registration on the State Health Society Bihar haemophilia portal
Documents Required to be Attached
To avail benefits under Mukhyamantri Haemophilia Yojana, applicants need to submit documents that establish their haemophilia diagnosis, Bihar residency, and eligibility for assistance. Keeping all documents ready in advance can help ensure a smoother verification process.
- Aadhaar Card
- Residential Certificate, confirming Bihar domicile, issued by a competent authority
- Diagnostic report or medical prescription, confirming Haemophilia A or Haemophilia B diagnosis, issued by a Government Medical College Hospital
- Income Certificate, reflecting the family’s financial status
- Passport size photograph
- Registration confirmation from the State Health Society Bihar Thalassemia and Hemophilia Portal
How Beneficiaries Can Apply to Avail the Benefit of the Scheme
Since Mukhyamantri Haemophilia Yojana has been approved only recently, a separate application form and detailed implementation process have not been released yet. However, based on the information available so far, here’s how beneficiaries are expected to access treatment under the scheme.
What’s Reasonably Expected to Happen
Step 1: Visit your nearest government medical college hospital that provides haemophilia treatment services, such as PMCH Patna, SKMCH Muzaffarpur, JLNMCH Bhagalpur, AIIMS Patna, GMC Purnia, or ANMMCH Gaya.
Step 2: If your condition has not already been confirmed, undergo the required laboratory tests and medical evaluation to establish a diagnosis of Haemophilia A or Haemophilia B.
Step 3: Complete your registration on the State Health Society Bihar’s Thalassemia and Hemophilia portal. This registration helps the Health Department maintain records of eligible patients and plan treatment support.
Step 4: Meet your treating doctor and share all medical reports. The doctor will carefully assess your condition and determine whether Emicizumab therapy is appropriate for you.
Step 5: Once the government issues detailed operational guidelines, eligible patients are expected to receive medicines through designated haemophilia treatment centres and daycare facilities under the scheme.
What You Can Do Right Now
Step 1: Keep all important documents ready, including your diagnostic reports, Bihar residential certificate, Aadhaar Card, income certificate, and recent passport size photographs.
Step 2: Stay connected with your treating hospital, district Civil Surgeon, Chief Medical Officer, or the State Health Society Bihar for the latest announcements regarding implementation and medicine distribution.
Important: Detailed operational guidelines, the final distribution process, and hospital-wise rollout arrangements are still under preparation. Until official instructions are released, avoid relying on any private website, agent, or individual claiming to accept applications. For accurate updates, follow information issued by the State Health Society Bihar and recognised government medical institutions only.
Important Links Available of the Scheme
- State Health Society Bihar Thalassemia and Hemophilia Portal
- Official Information About Haemophilia and Available Services
Contact Details in Case of Help Needed
- Nodal Department: Health Department, Government of Bihar
- Implementing Body: State Health Society, Bihar
- Address: Parivar Kalyan Bhavan, Sheikhpura, Patna
- Phone: +91-612-2290328
- Email: datacentreshsbnew@gmail.com
- Local Level: Contact your nearest government medical college hospital, or your District Civil Surgeon
Frequently Asked Questions (FAQs)
Ans. Mukhyamantri Haemophilia Yojana is a Bihar Government initiative approved by the State Cabinet to provide free Emicizumab treatment to eligible haemophilia patients through government healthcare institutions across the state.
Ans. Permanent residents of Bihar diagnosed with Haemophilia A or Haemophilia B and registered on the State Health Society Bihar’s Thalassemia and Hemophilia portal are eligible to receive benefits under the scheme.
Ans. The scheme provides access to Emicizumab, an advanced non factor therapy used in the management of haemophilia, helping reduce the frequency of bleeding episodes and improving quality of life.
Ans. The Bihar Cabinet has approved the scheme. However, detailed operational guidelines and the complete beneficiary enrollment process are expected to be issued separately by the Health Department.
Ans. The Bihar Government has approved an expenditure of approximately Rs. 26.33 crore for the first year to procure Emicizumab and support eligible patients.
Ans. Emicizumab is a highly effective but expensive medicine. By providing it through government support, the scheme reduces the financial burden on families and improves access to modern haemophilia treatment.
Ans. Around 255 registered haemophilia patients across Bihar are expected to benefit during the initial phase of implementation.
Ans. Treatment will be provided through Bihar’s Integrated Centre for Hemoglobinopathies and Haemophilia network and designated government medical college hospitals, including PMCH Patna, SKMCH Muzaffarpur, JLNMCH Bhagalpur, AIIMS Patna, GMC Purnia, and ANMMCH Gaya.
Ans. Yes. Mukhyamantri Chikitsa Sahayata Yojana covers financial assistance for various serious illnesses, whereas Mukhyamantri Haemophilia Yojana specifically focuses on providing advanced treatment support for haemophilia patients.
Ans. Yes. Registration on the State Health Society Bihar’s Thalassemia and Hemophilia portal is expected to remain an important requirement for identification and treatment support under the scheme.
Ans. You can contact your nearest government medical college hospital, District Civil Surgeon, or the State Health Society Bihar for guidance and the latest updates regarding the scheme’s implementation.
Tabassum is a government schemes researcher and writer with 5 years of experience tracking Central and State welfare scheme programmes across India. She has covered 500+ schemes spanning agriculture, women welfare, education, and housing, helping lakhs of beneficiaries understand their entitlements in simple language.